Ibio vs Vivosim Labs
Vivosim Labs is the larger business, with $131,000 of revenue in fiscal 2026 against $100,000 for Ibio (1.3 times as much). Vivosim Labs grew faster (-9.0% against -75.0%). Vivosim Labs kept more of each dollar of sales as profit: a net margin of -10567.2% against -33044.0%.
| Latest fiscal year | IbioIBIO, 2026 | Vivosim LabsVIVS, 2026 |
|---|---|---|
| Revenue | $100,000 | $131,000 |
| Revenue growth | -75.0% | -9.0% |
| Net income | −$33.0m | −$13.8m |
| Operating margin | -35141.0% | -8768.7% |
| Net margin | -33044.0% | -10567.2% |
| Return on equity | -65.7% | — |
| Free cash flow | −$23.8m | −$10.8m |
| Cash | $56.4m | $5.0m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 23 | 15 |
| Market value | $45.5m | $457,742 |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | 18 (Weak) |
| Insider trades, 12 months | 4 buys, 0 sales | 1 buys, 1 sales |